| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.767 | 0.02 | 0.806 | Antiinflammatory | 0.806 0.014 CID_154699797 | CID_154699797 | |
| 0.748 | 0.004 | 0.748 | Immunosuppressant | 0.747 0.004 CID_154699797 | ||
| 0.637 | 0.027 | 0.693 | Transcription factor NF kappa B inhibitor | 0.693 0.021 CID_154699797 | CID_154699797 | |
| 0.609 | 0.047 | 0.609 | Apoptosis agonist | 0.557 0.059 CID_154699797 | ||
| 0.513 | 0.018 | 0.513 | Caspase 3 stimulant | 0.459 0.027 CID_154699797 | ||
| 0.495 | 0.016 | 0.495 | Nitric oxide antagonist | 0.453 0.02 CID_154699797 | ||
| 0.506 | 0.057 | 0.506 | Caspase 9 stimulant | 0.485 0.066 CID_154699797 | ||
| 0.366 | 0.034 | 0.366 | Hypoglycemic | 0.363 0.035 CID_154699797 | ||
| 0.371 | 0.041 | 0.371 | Antioxidant | 0.363 0.043 CID_154699797 | ||
| 0.355 | 0.047 | 0.355 | Calcium channel activator | 0.3 0.091 CID_154699797 | ||
| 0.37 | 0.091 | 0.405 | Antibacterial | 0.405 0.075 CID_154699797 | CID_154699797 | |
| 0.313 | 0.041 | 0.313 | Antimitotic | 0.22 0.074 CID_154699797 | ||
| 0.287 | 0.031 | 0.287 | P-glycoprotein inhibitor | 0.227 0.05 CID_154699797 | ||
| 0.244 | 0.01 | 0.244 | Microtubule formation inhibitor | 0.24 0.011 CID_154699797 | ||
| 0.264 | 0.045 | 0.264 | Platelet adhesion inhibitor | 0.136 0.123 CID_154699797 | ||
| 0.221 | 0.005 | 0.221 | Prostaglandin EP2 antagonist | 0.188 0.007 CID_154699797 | ||
| 0.267 | 0.062 | 0.267 | Free radical scavenger | 0.218 0.084 CID_154699797 | ||
| 0.247 | 0.044 | 0.247 | Hepatoprotectant | 0.236 0.048 CID_154699797 | ||
| 0.23 | 0.032 | 0.232 | Interferon gamma antagonist | 0.232 0.032 CID_154699797 | CID_154699797 | |
| 0.249 | 0.07 | 0.249 | Vasodilator | 0.19 0.113 CID_154699797 | ||
| 0.186 | 0.023 | 0.186 | Antineoplastic antibiotic | 0.173 0.026 CID_154699797 | ||
| 0.271 | 0.11 | 0.283 | Antithrombotic | 0.283 0.1 CID_154699797 | CID_154699797 | |
| 0.191 | 0.032 | 0.191 | Protein-tyrosine phosphatase 1B inhibitor | 0.126 0.058 CID_154699797 | ||
| 0.166 | 0.008 | 0.166 | Calcium channel L-type blocker | 0.147 0.01 CID_154699797 | ||
| 0.252 | 0.095 | 0.352 | Immunostimulant | 0.352 0.064 CID_154699797 | CID_154699797 | |
| 0.158 | 0.005 | 0.158 | Neuraminidase inhibitor | 0.146 0.006 CID_154699797 | ||
| 0.263 | 0.115 | 0.337 | Apoptosis antagonist | 0.337 0.062 CID_154699797 | CID_154699797 | |
| 0.16 | 0.013 | 0.16 | Anabolic | 0.151 0.017 CID_154699797 | ||
| 0.186 | 0.047 | 0.186 | NOS3 expression enhancer | 0.159 0.064 CID_154699797 | ||
| 0.163 | 0.024 | 0.163 | Papain-like protease (SARS coronavirus) inhibitor | 0.145 0.039 CID_154699797 | ||
| 0.167 | 0.038 | 0.167 | Adenylate cyclase stimulant | 0.166 0.039 CID_154699797 | ||
| 0.135 | 0.02 | 0.135 | Transcription factor NF kappa B stimulant | 0.129 0.022 CID_154699797 | ||
| 0.172 | 0.061 | 0.172 | Protein-tyrosine phosphatase inhibitor | 0.125 0.108 CID_154699797 | ||
| 0.168 | 0.061 | 0.17 | Melanin inhibitor | 0.17 0.059 CID_154699797 | CID_154699797 | |
| 0.166 | 0.07 | 0.184 | Arachidonic acid antagonist | 0.184 0.05 CID_154699797 | CID_154699797 | |
| 0.108 | 0.012 | 0.108 | Androgen agonist | 0.098 0.015 CID_154699797 | ||
| 0.103 | 0.017 | 0.103 | Estrogen agonist | 0.078 0.024 CID_154699797 | ||
| 0.201 | 0.119 | 0.316 | Spasmolytic | 0.316 0.064 CID_154699797 | CID_154699797 | |
| 0.084 | 0.004 | 0.084 | Microtubule stabilization | 0.074 0.005 CID_154699797 | ||
| 0.125 | 0.046 | 0.125 | Estrogen antagonist | 0.119 0.056 CID_154699797 | ||
| 0.123 | 0.055 | 0.123 | TRPA1 agonist | |||
| 0.097 | 0.029 | 0.097 | Estrogen receptor alpha antagonist | 0.083 0.044 CID_154699797 | ||
| 0.139 | 0.077 | 0.153 | Protein kinase stimulant | 0.153 0.066 CID_154699797 | CID_154699797 | |
| 0.115 | 0.054 | 0.115 | Electron transport complex I inhibitor | 0.107 0.067 CID_154699797 | ||
| 0.08 | 0.022 | 0.08 | Calcium channel T-type blocker | |||
| 0.065 | 0.01 | 0.065 | Squalene synthetase inhibitor | 0.043 0.017 CID_154699797 | ||
| 0.119 | 0.065 | 0.167 | Cholesterol synthesis inhibitor | 0.167 0.037 CID_154699797 | CID_154699797 | |
| 0.092 | 0.039 | 0.095 | Na+ K+ transporting ATPase inhibitor | 0.095 0.036 CID_154699797 | CID_154699797 | |
| 0.125 | 0.072 | 0.125 | Cyclooxygenase 3 inhibitor | 0.124 0.073 CID_154699797 | ||
| 0.066 | 0.019 | 0.066 | Pregnane X receptor antagonist | 0.061 0.028 CID_154699797 | ||
| 0.138 | 0.095 | 0.138 | Sigma receptor agonist | |||
| 0.123 | 0.081 | 0.126 | Vanilloid 1 agonist | 0.126 0.075 CID_154699797 | CID_154699797 | |
| 0.108 | 0.068 | 0.123 | Mucolytic | 0.123 0.051 CID_154699797 | CID_154699797 | |
| 0.046 | 0.014 | 0.046 | RNA-directed RNA polymerase stimulant | 0.039 0.017 CID_154699797 | ||
| 0.084 | 0.053 | 0.084 | T cell inhibitor | 0.078 0.073 CID_154699797 | ||
| 0.066 | 0.038 | 0.066 | Nitric oxide donor | 0.065 0.04 CID_154699797 | ||
| 0.06 | 0.031 | 0.06 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.195 | 0.169 | 0.242 | Cholesterol antagonist | 0.242 0.131 CID_154699797 | CID_154699797 | |
| 0.085 | 0.061 | 0.09 | Ornithine decarboxylase inhibitor | 0.09 0.056 CID_154699797 | CID_154699797 | |
| 0.08 | 0.057 | 0.08 | Glycine receptor antagonist | |||
| 0.153 | 0.133 | 0.153 | Hypolipemic | |||
| 0.037 | 0.019 | 0.037 | Tubulin agonist | 0.034 0.025 CID_154699797 | ||
| 0.04 | 0.022 | 0.04 | Retinoid X receptor agonist | 0.04 0.022 CID_154699797 | ||
| 0.029 | 0.014 | 0.03 | Retinoid X gamma receptor antagonist | 0.03 0.013 CID_154699797 | CID_154699797 | |
| 0.033 | 0.019 | 0.033 | Prostaglandin EP3 antagonist | 0.026 0.025 CID_154699797 | ||
| 0.175 | 0.162 | 0.195 | DNA synthesis inhibitor | 0.195 0.13 CID_154699797 | CID_154699797 | |
| 0.037 | 0.026 | 0.037 | 5-Alpha-reductase inhibitor | |||
| 0.017 | 0.007 | 0.017 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.016 0.009 CID_154699797 | ||
| 0.034 | 0.025 | 0.034 | Retinoid X alpha receptor agonist | 0.034 0.025 CID_154699797 | ||
| 0.034 | 0.025 | 0.034 | HMG CoA reductase inhibitor | |||
| 0.024 | 0.015 | 0.024 | Retinoid X gamma receptor agonist | 0.023 0.016 CID_154699797 | ||
| 0.038 | 0.03 | 0.042 | Retinoic acid alpha receptor agonist | 0.042 0.023 CID_154699797 | CID_154699797 | |
| 0.012 | 0.007 | 0.012 | Calcineurin inhibitor | 0.011 0.008 CID_154699797 | ||
| 0.129 | 0.124 | 0.131 | Ca2+-transporting ATPase inhibitor | 0.131 0.115 CID_154699797 | CID_154699797 | |
| 0.108 | 0.103 | 0.114 | Calcium channel blocker | 0.114 0.094 CID_154699797 | CID_154699797 | |
| 0.039 | 0.035 | 0.039 | Kainate receptor agonist | |||
| 0.019 | 0.017 | 0.019 | Retinoid X beta receptor agonist | 0.019 0.017 CID_154699797 | ||
| 0.087 | 0.085 | 0.101 | Expectorant | 0.101 0.068 CID_154699797 | CID_154699797 | |
| 0.047 | 0.046 | 0.047 | Glucose-6-phosphate translocase inhibitor | |||
| 0.196 | 0.196 | 0.236 | Interleukin 2 agonist | 0.236 0.135 CID_154699797 | CID_154699797 | |
| 0.027 | 0.027 | 0.029 | Prostaglandin D2 agonist | 0.029 0.023 CID_154699797 | CID_154699797 | |
| 0.02 | 0.021 | 0.021 | Retinoic acid receptor agonist | 0.021 0.019 CID_154699797 | CID_154699797 | |
| 0.019 | 0.025 | 0.021 | Retinoic acid gamma receptor agonist | 0.021 0.02 CID_154699797 | CID_154699797 | |
| 0.109 | 0.115 | 0.112 | Neurotrophic factor | 0.112 0.109 CID_154699797 | CID_154699797 | |
| 0.123 | 0.157 | 0.135 | Lipocortins synthesis antagonist | 0.135 0.13 CID_154699797 | CID_154699797 | |
| 0.05 | 0.086 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.057 CID_154699797 | CID_154699797 | |
| 0.14 | 0.225 | 0.2 | Peptidyltransferase inhibitor | 0.2 0.099 CID_154699797 | CID_154699797 | |
| 0.1 | 0.221 | 0.204 | Platelet antagonist | 0.204 0.098 CID_154699797 | CID_154699797 | |
| 0.057 | 0.194 | 0.083 | Ca(v)3.1 blocker | 0.083 0.052 CID_154699797 | CID_154699797 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |